Vijaypd Ceutical IPO Listing at 0.29% Premium at ₹35.10 Per Share

Tue Oct 07 2025

Click and Sign Up to Get Latest Updates on Vijaypd Ceutical Limited

Vijaypd Ceutical IPO Listing: The Vijaypd Ceutical IPO was subscribed 1.37 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received [.] times the allocation, and non-institutional investors (NIIs) received 1.86 times the allocation. The retail quota of the issue was subscribed to 47.42%. Before delving deeper into the topic, go through the details of the Vijaypd Ceutical IPO.

Table of Contents

Vijaypd Ceutical IPO Listing

On the NSE (National Stock Exchange), shares are listed at ₹35.10 per share, representing a 0.29% premium over the issue price of ₹35.10.

Vijaypd Ceutical IPO Details

It is a book-building IPO of ₹19.25 crores, comprising an entirely fresh issue of ₹0.55 crore. The problem will be listed on NSE and SME on its tentative listing date, 7th October 2025.

The Vijaypd Ceutical IPO date is scheduled between September 29, 2025, and October 1, 2025. The face value of Vijaypd Ceutical’s IPO shares is ₹10 per share, and the IPO price is set at ₹35 per share.

IPO Open Date	29th September 2025
IPO Close Date	1st October 2025
IPO Allotment Date	3rd October 2025
Refund Initiation	6th October 2025
Issue Size	55,00,000 shares(aggregating up to ₹19.25 Cr)
Face Value	₹10 per share
Lot Size	4,000 shares
Issue Price Final	₹35 per Share
Issue Type	Bookbuilding IPO
Listing At	NSE & NSE
Listing Date	7th October 2025

About Vijaypd Ceutical Limited

Vijaypd Ceutical Limited was established in October 1971. The company distributes pharmaceutical products and consumer goods, offering a comprehensive range of services. The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers. The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs. As of March 31, 2025, the company serves over 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations. The company’s distribution network is connected to over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.

Vijaypd Ceutical Limited Financials

The company’s financial analysis is essential before applying for the Vijaypd Ceutical IPO. Refer to the table to learn about Vijaypd Ceutical Limited’s financial information.

Year Ended	31st March 2024 (in cr.)	31st March 2023 (in cr.)	31st March 2022 (in cr)
Assets	57.15	33.27	32.87
Revenue	107.59	54.34	50.59
Profit After Tax	4.80	1.65	0.18
Net Worth	32.17	1.00	4.93
EBITDA	8.59	4.87	1.32
Reserve and Surplus	18.14	–	–
Total Borrowing	21.77	30.04	25.56

Explanation

Vijaypd Ceutical Limited’s revenue increased by 98% from ₹54.64 crores in March 2024 to ₹107.59 crores in March 2025. Moreover, the company’s PAT rose by 191% from ₹1.65 crores to ₹4.80 crores.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!